(Q33838161)

29 July 2017

1 reference

title

Proteases in gastrointestinal neoplastic diseases (English)

1 reference

29 July 2017

Herszényi L

1

1 reference

29 July 2017

Plebani M

2

1 reference

29 July 2017

Carraro P

3

1 reference

29 July 2017

De Paoli M

4

1 reference

29 July 2017

Roveroni G

5

1 reference

29 July 2017

Cardin R

6

1 reference

29 July 2017

Foschia F

7

1 reference

29 July 2017

Tulassay Z

8

1 reference

29 July 2017

Naccarato R

9

1 reference

29 July 2017

Farinati F

10

1 reference

29 July 2017

1 February 2000

1 reference

29 July 2017

1 reference

29 July 2017

291

1 reference

29 July 2017

171-187

1 reference

29 July 2017

2

1 reference

Biology of tumour metastasis

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Current concepts in metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Tumor invasion: a consequence of destructive and compositional matrix alterations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Cathepsin B and its endogenous inhibitors: the role in tumor malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Cytokine-induced pseudopodial protrusion is coupled to tumour cell migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Immunocytochemical localization of cathepsin B in rat kidney. I. Light microscopic study using the indirect immunoenzyme technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

The distribution of cathepsin B in human tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

The plasminogen activator/plasmin system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

The urokinase receptor: involvement in cell surface proteolysis and cancer invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

The role of the urokinase receptor in extracellular matrix degradation by HT29 human colon carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Urokinase receptor is a key player in tumour progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Role of urokinase, its receptor, and serpins in colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Regulation of plasminogen activator inhibitor activity by plasmin in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

The role of plasminogen activators in the regulation of connective tissue metalloproteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Proteolytic enzymes as mediators of glomerular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Tissue destruction by neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

The role of proteolytic enzymes in cancer invasion and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Cystatin C and cathepsin B in human colon carcinoma: expression by cell lines and matrix degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Pancreatic trypsinogen and cathepsin B in human pancreatic carcinomas and associated metastatic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

The plasminogen-plasmin system in malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Isolation and characterization of plasminogen activators from hyperlastic and malignant prostate tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Differential protease expression by cutaneous squamous and basal cell carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Plasminogen activator inhibitor-type 1 in Lewis lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Proteinase-like peptidase activities in malignant and non-malignant gastric tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Cathepsin B and L activities in gastric cancer tissue: correlation with histological findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Protease activities in gastric cancer tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Plasminogen activators in human gastric cancers: correlation with DNA ploidy and immunohistochemical staining

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Cysteine and serine proteases in gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Urokinase-type plasminogen activator receptor in gastric cancer: tissue expression and prognostic role

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Cysteine endopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Urokinase type plasminogen activator receptor expression in colorectal neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Increased levels of cathepsin B and L, urokinase-type plasminogen activator and its inhibitor type-1 as an early event in gastric carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Location of plasminogen activator (PA) and PA inhibitor in human colorectal adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Association between plasma concentrations of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

Serum cathepsin B levels and urinary excretion of cathepsin B in the cancer patients with remote metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900227-2

10.1016/S0009-8981(99)00227-2

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference